Tenex Health receives FDA clearance for TX-Bone device — 4 key insights

Written by Alan Condon | May 15, 2019 | Print  |

Lake Forest, Calif.-based medical device company, Tenex Health, received FDA approval to market its latest minimally invasive technology, TX-Bone.

Four key insights:

1. TX-Bone is designed to remove pain-causing bone and calcific tissue, helping patients restore musculoskeletal function.

2. The technology is fed through a small incision, using an ultrasound or palpation guided technique.

3. It allows physicians to simultaneously identify and perform selective cutting and removal of pain-generating bone and calcific tissue, utilizing optimized ultrasound energy.

4. Applications of the TX-Bone technology include rotator cuffs, triceps, the gluteus/trochanteric region, Achilles tendon insertion, Haglund's deformity and plantar fascia insertion spurs.

"TX-Bone represents a major advancement in the management of patients with tendinopathy, including those who suffer from bony spurs," said Bernard Morrey, MD, of the Mayo Clinic in Rochester, Minn.

More articles on devices:
Reflexion Health receives FDA clearance for VERA — 4 takeaways
Medicrea hosts 2nd annual meeting on AI and analytics in New York: 3 things to know
Xenco Medical launches 1st interactive vending machine for spine surgery instruments — 4 insights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers